FERLAY J E M , LAM Breast cancer overtakes lung cancer in terms of number of new cancer cases worldwide [M ] . 2021 .

PANTEL K , HAYES D F . Disseminated breast tumour cells: biological and clinical meaning [J ] . Nat Rev Clin Oncol , 2018 , 15 ( 3 ): 129 - 131 .

MAKHOUL I , MONTGOMERY C O , GADDY D , et al . The best of both worlds-managing the cancer, saving the bone [J ] . Nat Rev Endocrinol , 2016 , 12 ( 1 ): 29 - 42 .

WORTZEL I , DROR S , KENIFIC C M , et al . Exosome-mediated metastasis: communication from a distance [J ] . Dev Cell , 2019 , 49 ( 3 ): 347 - 360 .

GUO Y X , JI X , LIU J B , et al . Effects of exosomes on pre-metastatic niche formation in tumors [J ] . Mol Cancer , 2019 , 18 ( 1 ): 39 .

SUPAKUL S , YAO K T , OCHI H , et al . Pericytes as a source of osteogenic cells in bone fracture healing [J ] . Int J Mol Sci , 2019 , 20 ( 5 ): 1079 .

PANG X , GONG K , ZHANG X , et al . Osteopontin as a multifaceted driver of bone metastasis and drug resistance [J ] . Pharmacol Res , 2019 , 144 : 235 - 244 .

HOFBAUER L C , BOZEC A , RAUNER M , et al . Novel approaches to target the microenvironment of bone metastasis [J ] . Nat Rev Clin Oncol , 2021 , 18 ( 8 ): 488 - 505 .

DAS S , CLÉZARDIN P , KAMEL S , et al . The CaSR in pathogenesis of breast cancer: a new target for early stage bone metastases [J ] . Front Oncol , 2020 , 10 : 69 .

WU X Q , LI F F , DANG L , et al . RANKL/RANK system-based mechanism for breast cancer bone metastasis and related therapeutic strategies [J ] . Front Cell Dev Biol , 2020 , 8 : 76 .

LUO G J , HE Y D , ZHAO Q , et al . Immune cells act as promising targets for the treatment of bone metastasis [J ] . Recent Pat Anticancer Drug Discov , 2017 , 12 ( 3 ): 221 - 233 .

COLEMAN R E , CROUCHER P I , PADHANI A R , et al . Bone metastases [J ] . Nat Rev Dis Primers , 2020 , 6 ( 1 ): 83 .

WANG K Y , GU Y , LIAO Y H , et al . PD-1 blockade inhibits osteoclast formation and murine bone cancer pain [J ] . J Clin Invest , 2020 , 130 ( 7 ): 3603 - 3620 .

HARARI A , GRACIOTTI M , BASSANI-STERNBERG M , et al . Antitumour dendritic cell vaccination in a priming and boosting approach [J ] . Nat Rev Drug Discov , 2020 , 19 ( 9 ): 635 - 652 .

LIANG S , ZHENG J , WU W , et al . A robust nanoparticle platform for RNA interference in macrophages to suppress tumor cell migration [J ] . Front Pharmacol , 2018 , 9 : 1465 .

GEORGE C N , CANUAS-LANDERO V , THEODOULOU E , et al . Oestrogen and zoledronic acid driven changes to the bone and immune environments: potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions [J ] . J Bone Oncol , 2020 , 25 : 100317 .

SUN W T , GE K , JIN Y , et al . Bone-targeted nanoplatform combining zoledronate and photothermal therapy to treat breast cancer bone metastasis [J ] . ACS Nano , 2019 , 13 ( 7 ): 7556 - 7567 .

GNANT M , PFEILER G , STEGER G G , et al . Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial [J ] . Lancet Oncol , 2019 , 20 ( 3 ): 339 - 351 .

COLEMAN R , FINKELSTEIN D M , BARRIOS C , et al . Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial [J ] . Lancet Oncol , 2020 , 21 ( 1 ): 60 - 72 .

JEONG H , JEONG J H , KIM J E , et al . Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancer [J ] . Int J Cancer , 2021 .

XU J , HIGGINS M J , TOLANEY S M , et al . A phase Ⅱ trial of cabozantinib in hormone receptor-positive breast cancer with bone metastases [J ] . Oncologist , 2020 , 25 ( 8 ): 652 - 660 .

ZHENG H Q , BAE Y J , KASIMIR-BAUER S , et al . Therapeutic antibody targeting tumor- and osteoblastic niche-derived Jagged1 sensitizes bone metastasis to chemotherapy [J ] . Cancer Cell , 2017 , 32 ( 6 ): 731 - 747 .e6.

COSMAN F , CRITTENDEN D B , ADACHI J D , et al . Romosozumab treatment in postmenopausal women with osteoporosis [J ] . N Engl J Med , 2016 , 375 ( 16 ): 1532 - 1543 .

HESSE E , SCHRÖDER S , BRANDT D , et al . Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness [J ] . JCI Insight , 2019 , 4 ( 9 ): e125543 .

SPRAVE T , VERMA V , FÖRSTER R , et al . Randomized phase Ⅱ trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy [J ] . Radiother Oncol , 2018 , 128 ( 2 ): 274 - 282 .

SPRAVE T , VERMA V , FÖRSTER R , et al . Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial [J ] . BMC Cancer , 2018 , 18 ( 1 ): 859 .

UENO N T , TAHARA R K , FUJII T , et al . Phase Ⅱ study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancer [J ] . Cancer Med , 2020 , 9 ( 3 ): 1025 - 1032 .

Study of radium-223 dichloride versus placebo and hormonal treatment as background therapy in subjects with bone predominant HER2 (human epidermal growth factor receptor 2) negative hormone receptor positive metastatic breast cancer [M ] .

KERNEL N N I . Testing the addition of radium therapy (radium-223 dichloride) to the usual chemotherapy treatment (paclitaxel) for advanced breast cancer spread to the bones [J ] . Case Med Res , 2019 .

LEI W , DUAN R , LI J B , et al . The IAP antagonist SM-164 eliminates triple-negative breast cancer metastasis to bone and lung in mice [J ] . Sci Rep , 2020 , 10 ( 1 ): 7004 .

LU Z H , ZOU J L , LI S , et al . Epigenetic therapy inhibits metastases by disrupting premetastatic niches [J ] . Nature , 2020 , 579 ( 7798 ): 284 - 290 .